Olema Pharmaceuticals, Inc.

XNASHealth care

Last traded price · USD

$7.54

+0.00%Delayed · Pre-market

Delayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 15:07 IST · A quote does not mean the product is available to trade on your account.

Day's open: —
Previous close: $7.54
Volume: —
Day's high: —
Day's low: —

In brief

Olema Pharmaceuticals, Inc. is a health care company listed on Nasdaq, valued at about $660M.
Its shares closed at $7.54 on 4 Nov 2026, down 8.0% over the past year.
From India you can buy OLMA in US dollars under the RBI's Liberalised Remittance Scheme, including a fraction of one share. See what it costs

Questions investors ask

Can I buy Olema Pharmaceuticals, Inc. (OLMA) shares from India?

Yes. Indian residents can invest in the US stock market under the Reserve Bank of India's Liberalised Remittance Scheme (LRS), which lets a resident individual remit up to USD 250,000 per financial year, across all permitted purposes combined. US-listed stocks and ETFs are a permitted investment under the LRS. You are solely responsible for ensuring your remittances comply with the LRS annual limit, the applicable Tax Collected at Source (TCS) rules, and all reporting requirements, including Schedule FA in your income-tax return.

Do I need the price of a whole OLMA share to invest?

Yes. You can buy fractional shares, which lets you invest a fixed rupee/dollar amount even in high-priced stocks. For example, if one share trades at USD 1,000 and you invest USD 100, you receive 0.1 of a share.

How much can I invest in US stocks in a year?

Under the LRS, an Indian resident can remit up to USD 250,000 per financial year (April to March) across all permitted purposes combined, from their own funds. This is a per-individual limit set by the RBI.

Can I trade OLMA options or futures?

No. Under RBI / FEMA rules, the LRS does not permit margin trading or speculative instruments such as futures, options, or other derivatives. Your US account is a cash account, not a derivatives and margin account.

Insights

Quotes run fifteen minutes behind.

Behind SPY and its sector fund XLV over 1 year
1 month: −4.8% (SPY −1.6%, XLV +13.5%). 3 months: −34.9% (SPY −0.4%, XLV +15.5%). 1 year: −8.0% (SPY +13.6%, XLV +30.7%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: OLMA, SPY and XLV · as of 4 Nov 2026
20.9% above its 52-week low
Closed at $7.54 on 4 Nov 2026: 79.2% below the 52-week high of $36.26 (16 Dec 2025) and 20.9% above the low of $6.24 (23 Oct 2026).
Daily price bars, split-adjusted · as of 4 Nov 2026
13.4 days to cover short interest
15.7M shares were sold short at the 15 Oct 2026 settlement, 17.9% of the 87.5M shares outstanding; covering them would take 13.4 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026
Below its 50- and 200-day averages
The 4 Nov 2026 close of $7.54 was 12.7% below its 50-day average ($8.64) and 45.0% below its 200-day average ($13.72). It has closed below the 200-day for 136 sessions, since 23 Apr 2026. The 50-day average crossed below the 200-day on 11 May 2026, 123 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026

Returns

Price return, split-adjusted

At the 4 Nov 2026 close

1 month−4.8%

6 months−50.4%

1 year−8.0%

5 years−73.8%

Newswire

About

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

Website

Notable moves

November 18, 2025
+136.38%
September 5, 2025
+30.87%
November 30, 2021
−60.02%

Olema Pharmaceuticals, Inc.

XNASHealth care

Last traded price · USD

$7.54

+0.00%Delayed · Pre-market

Delayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 15:07 IST · A quote does not mean the product is available to trade on your account.

Day's open: —
Previous close: $7.54
Volume: —
Day's high: —
Day's low: —

In brief

Olema Pharmaceuticals, Inc. is a health care company listed on Nasdaq, valued at about $660M.
Its shares closed at $7.54 on 4 Nov 2026, down 8.0% over the past year.
From India you can buy OLMA in US dollars under the RBI's Liberalised Remittance Scheme, including a fraction of one share. See what it costs

Questions investors ask

Can I buy Olema Pharmaceuticals, Inc. (OLMA) shares from India?

Do I need the price of a whole OLMA share to invest?

How much can I invest in US stocks in a year?

Can I trade OLMA options or futures?

Insights

Quotes run fifteen minutes behind.

Behind SPY and its sector fund XLV over 1 year
1 month: −4.8% (SPY −1.6%, XLV +13.5%). 3 months: −34.9% (SPY −0.4%, XLV +15.5%). 1 year: −8.0% (SPY +13.6%, XLV +30.7%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: OLMA, SPY and XLV · as of 4 Nov 2026
20.9% above its 52-week low
Closed at $7.54 on 4 Nov 2026: 79.2% below the 52-week high of $36.26 (16 Dec 2025) and 20.9% above the low of $6.24 (23 Oct 2026).
Daily price bars, split-adjusted · as of 4 Nov 2026
13.4 days to cover short interest
15.7M shares were sold short at the 15 Oct 2026 settlement, 17.9% of the 87.5M shares outstanding; covering them would take 13.4 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026
Below its 50- and 200-day averages
The 4 Nov 2026 close of $7.54 was 12.7% below its 50-day average ($8.64) and 45.0% below its 200-day average ($13.72). It has closed below the 200-day for 136 sessions, since 23 Apr 2026. The 50-day average crossed below the 200-day on 11 May 2026, 123 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026

Returns

Price return, split-adjusted

At the 4 Nov 2026 close

1 month−4.8%

6 months−50.4%

1 year−8.0%

5 years−73.8%

Newswire

About

Website

Notable moves

November 18, 2025
+136.38%
September 5, 2025
+30.87%
November 30, 2021
−60.02%

Olema Pharmaceuticals, Inc.

Olema Pharmaceuticals, Inc. in brief

Behind SPY and its sector fund XLV over 1 year

20.9% above its 52-week low

13.4 days to cover short interest

Below its 50- and 200-day averages

Olema Pharmaceuticals, Inc.

Olema Pharmaceuticals, Inc. in brief

Behind SPY and its sector fund XLV over 1 year

20.9% above its 52-week low

13.4 days to cover short interest

Below its 50- and 200-day averages